Concepedia

Publication | Closed Access

Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years

140

Citations

23

References

2016

Year

Abstract

clinicaltrials.gov Identifier: NCT00413946.

References

YearCitations

Page 1